Chargement en cours...
Clinical exacerbation of SARS‐CoV2 infection after fingolimod withdrawal
The role of disease‐modifying therapies in patients with autoimmune disorders during severe acute respiratory syndrome coronavirus 2 (SARS‐CoV2) infection is controversial. Immunocompromised patients could have a more severe coronavirus disease‐2019 (COVID‐19) due to the absence of an adequate immun...
Enregistré dans:
| Publié dans: | J Med Virol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361541/ https://ncbi.nlm.nih.gov/pubmed/32644205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26279 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|